STAT+: Pharmalittle: We’re reading about payments to Russian middlemen, a possible Dupixent rival, and more
Summary
Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government entities
More from STAT News
Washington state resident dies from bird flu following exposure to infected cattleSTAT+: The health care affordability midterms, and billing urgent care as ERSTAT+: Psilocybin’s lasting benefits prove elusive in miceSTAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries